Field Safety Corrective Action

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 4

F/QP-29-04 Rev.

0
Page 1 of 4

Field Safety Corrective Action


----------------------------------
1. Administrative information
Name of national competent authority (NCA)

Address of national competent authority

Type of report
 Initial report
 Follow up report
 Final report
Date of this report

Reference number assigned by the manufacturer

Incidence number and name of the coordinating national competent authority (if applicable)

Identify to what other NCAs this report was also sent

2. Information on submitter of the report


Status of submitter
 Manufacturer
 Authorized representative within EEA, Switzerland and Turkey
 Others (identify the role):

3. Manufacturer information
Manufacturer name

Manufacturer's contact person

Address

City Postal code

Fax Phone

Country E-mail

4. Authorized representative information


Name of the authorized representative

The authorized representative's contact person

Address

City Postal code

Fax Phone

Country E-mail
F/QP-29-04 Rev.0
Page 2 of 4

5. National contact point information


National contact point name

Name of the contact person

Address

City Postal code

Fax Phone

Country E-mail

6. Medical device information


Class
 AIMD Active implants

 IVD Annex II List A  MDD Class III


 IVD Annex II List B  MDD Class IIb
 IVD Devices for self-testing  MDD Class IIa
 IVD General  MDD Class I

Nomenclature system (preferable GMDN)

Nomenclature code

Nomenclature text

Commercial name/brand name/make

Catalogue number Model number


Serial number(s) and/or Lot/batch number(s)

Software version number (if applicable)

Manufacturing date / Expiry date (if applicable)

Accessories / associated device (if applicable)

Notified body (NB) ID-number

7. Description of FSCA
Background information and reason for the FSCA

Description and justification of the action (corrective/preventive)

Advice on actions to be taken by the distributor and the user

Progress of FSCA , together with reconciliation data (Mandatory for a Final FSCA)
F/QP-29-04 Rev.0
Page 3 of 4

FSN status Attached please find


 Draft  Field Safety Notice (FSN) in English
 Final  FSN in national language
 Others (please specify):
Time schedule for the implementation of the different actions

These countries within the EEA and Switzerland are affected by this FSCA
Within EEA, Switzerland and Turkey:

 ES  EE  DK  DE  CZ  CY  CH  BU  BE  AT
 LT  LI  IT  IS  IE  HU  GR  GB  FR  FI
 SI  SE  RO  PT  PL  NO  NL  MT  LV  LU
 TR  SK

Candidate Countries:
 HR
 All EEA, Candidates Countries, Switzerland and Turkey

Others:

8.Comments

I affirm that the information given above is correct to the best of my knowledge.

……………………………………..
Signature

Name City Date

Note: Submission of this report does not, in itself, represent a conclusion by the manufacturer and/or
authorized representative or the national competent authority that the content of this report is complete or
accurate, that the medical device(s) listed failed in any manner and/or that the medical device(s) caused or
contributed to the alleged death or deterioration in the state of the health of any person.

AT=Austria, BE= Belgium, BU=Bulgaria, CY= Cyprus, CZ= Czech Republic, DK=Denmark, ES=
Estonia, FI= Finland, FR= France, GB= Germany, GR= Greece, HU= Hungary, IE= Iceland (EFTA), IS=
Ireland, IT= Italy, LV = Latvia, LI= Liechtenstein (EFTA), LT= Lithuania, LU= Luxembourg, MT= Malta,
NL= Netherlands, NO= Norway (EFTA), PL= Poland, PT= Portugal, RO= Romania, SE= Slovenia, SI=
Slovakia, Spain, Sweden, Switzerland(EFTA), TR= Turkey(Candidate), United Kingdom.
F/QP-29-04 Rev.0
Page 4 of 4

 ES  EE  DK  DE  CZ  CY  CH  BU  BE  AT
 LT  LI  IT  IS  IE  HU  GR  GB  FR  FI
 SI  SE  RO  PT  PL  NO  NL  MT  LV  LU
 SK

You might also like